Huikai Li

2 articles listing Huikai Li in Nature Communications, Science Advances, indexed by Paperzzz from Crossref and OSF.

1. Genome-wide screenings identify BAP1 as a synthetic-lethality target with CDK4/6 inhibitors Science Advances
2. Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial Nature Communications